首页 › 基金 › ABG-WTT Global Life Science Capital Partners GP Ltd › CBLL
ABG-WTT Global Life Science Capital Partners GP Ltd 对 CBLL 的持仓历史
CERIBELL INC · 医疗保健
ABG-WTT Global Life Science Capital Partners GP Ltd 在 Q2 2026 的 13F 申报中披露持有 CBLL(CERIBELL INC)275,328 股,市值约 US$5.4M,约占其申报组合的 62.61%,在其申报持仓中市值排名第 1 位。 ABG-WTT Global Life Science Capital Partners GP Ltd 最近 7 个申报季度中有 7 个季度披露了 CBLL 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
ABG-WTT Global Life Science Capital Partners GP Ltd 对 CBLL 的持仓演变
ABG-WTT Global Life Science Capital Partners GP Ltd 于 Q4 2024 首次披露 CBLL 持仓:1,088,101 股(约 US$28.2M)。 在 7 次申报中,ABG-WTT Global Life Science Capital Partners GP Ltd 0 次增持、2 次减持、4 次保持不变。 最近一期申报(Q2 2026)显示持股 275,328 股、市值约 US$5.4M,环比减持 -166,492 股。。 持仓曾出现大幅变动:Q4 2025 减持约 59% (随后一个季度股价下跌 16%)、Q2 2026 减持约 38% (随后一个季度股价上涨 25%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 1.09M | $28.16M | 新进 |
| Q1 2025 | 1.09M | $20.90M | 持有 |
| Q2 2025 | 1.09M | $20.38M | 持有 |
| Q3 2025 | 1.09M | $12.50M | 持有 |
| Q4 2025 | 441.82K | $9.69M | 减持 |
| Q1 2026 | 441.82K | $8.10M | 持有 |
| Q2 2026 | 275.33K | $5.36M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CBLL 与 13F 数据
CBLL(CERIBELL INC)属于医疗保健行业。我们追踪的基金中还有 60 只申报持有 CBLL,申报仓位最大的包括:TPG GP A, LLC (US$73.2M), Red Tree Management, LLC (US$53.8M), KCM Capital Inc (US$21.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CBLL 的基金
- TPG GP A, LLC 3.76M 股 · $73.15M · Q2 2026
- Red Tree Management, LLC 2.21M 股 · $53.80M · Q3 2026
- KCM Capital Inc 1.12M 股 · $21.88M · Q2 2026
- Redmile Group, LLC 386.79K 股 · $7.52M · Q2 2026
- Yu Fan 342.40K 股 · $6.66M · Q2 2026
- Creek Drive Management Group LLC 300.88K 股 · $5.85M · Q2 2026
更多关于 ABG-WTT Global Life Science Capital Partners GP Ltd
常见问题
How long has ABG-WTT Global Life Science Capital Partners GP Ltd held CBLL?
ABG-WTT Global Life Science Capital Partners GP Ltd has disclosed CBLL holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is ABG-WTT Global Life Science Capital Partners GP Ltd's current position in CBLL?
As of Q2 2026, ABG-WTT Global Life Science Capital Partners GP Ltd holds 275.33K shares of CBLL (CERIBELL INC), valued at $5.36M, representing 62.61% of its reported portfolio and ranking #1.
Has ABG-WTT Global Life Science Capital Partners GP Ltd been buying or selling CBLL?
In the latest 13F filing (Q2 2026), ABG-WTT Global Life Science Capital Partners GP Ltd reduced its position in CBLL.
Which other funds hold CBLL?
Other major institutional holders of CBLL include TPG GP A, LLC, Red Tree Management, LLC, KCM Capital Inc, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.